Virtu Financial’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Virtu Financial’s Portfolio LUMO Stock Details LUMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-10,556	Closed	-$38K	–	2234
2022 Q4	$38K	Buy	+10,556	New	+$69K	0.01%	1135
2019 Q2	–	Sell	-3,474	Closed	-$60K	–	1957
2019 Q1	$60K	Buy	+3,474	New	+$51.8K	﹤0.01%	1197
2018 Q1	–	Sell	-10,932	Closed	-$798K	–	2743
2017 Q4	$798K	Buy	+10,932	New	+$904K	0.04%	549

Other funds holding LUMO

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

JFG

Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

LPC

Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Virtu Financial's LUMO Position: Q1 2023 in Review

Virtu Financial sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q1 2023, closing a stake of 10,556 shares — an estimated $38K sold.

Virtu Financial first reported a position in LUMO in Q4 2017 and held it in 3 quarters. The position peaked at $798K in Q4 2017. 36 funds tracked by Wall St. Rank hold LUMO as of Q1 2023.

Virtu Financial reported no remaining Lumos Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Virtu Financial sold 10,556 Lumos Pharma, Inc. Common Stock shares in Q1 2023, an estimated $38K.
Virtu Financial first reported a position in Lumos Pharma, Inc. Common Stock in Q4 2017 and held it in 3 quarters.
Virtu Financial's Lumos Pharma, Inc. Common Stock position peaked at $798K in Q4 2017.
36 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q1 2023.

Based on Virtu Financial's 13F filing for Q1 2023, filed 1 May 2023.